Clinical Trial Update: Spironolactone Combined With Captopril and Carvedilol for the Treatment of Pulmonary Arterial Hypertension [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating a combination of spironolactone, captopril, and carvedilol for pulmonary arterial hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Pulmonary Hypertension

Drugs mentioned

• CAPTOPRIL (Captopril)
• CARVEDILOL (Carvedilol)
• Spironolactone (spironolactone)

Snippet

Sponsor: Hebei Medical University | Conditions: Hypertension, Pulmonary | Phase 1 | Status: COMPLETED